NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
We report a patient with advanced Parkinson's disease and treatment-resistant bipolar disorder in whom continuous subcutaneous foslevodopa/foscarbidopa infusion improved motor fluctuations without psychiatric destabilization despite prior dopaminergic sensitivity. This case suggests that LDp/CDp may be a therapeutic option even in patients with bipolar disorder.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.